Letter to the editor: Relationship between insulin resistance and malondialdehyde levels in dialysis patients [2]

Renal Failure

Volumn 29, Issue 5, 2007, Pages 649-651

  Taskapan, M C ^a,b   Keskin, Lezzan ^a   Sahin, Ibrahim ^a   Ozyalin, Fatma ^a   Atmaca, Hasan ^a   Temel, Ismail ^a   Taskapan, Hulya ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Cytokines; Dialysis; Insulin resistance; MDA; Oxidative stress

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TREATMENT DURATION; ADULT; BLOOD; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; HUMANS; INSULIN RESISTANCE; MALONDIALDEHYDE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS;

EID: 34547223187     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701392355     Document Type: Letter

References (8)

1. Mizuno T, Matsui H, Imamura A, et al. Insulin resistance increases circulating malondialdehyde-modified LDL and impairs endothelial function in healthy young men. Int J Cardiol. 2004;97(3):455-461.
2. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes. 2001;50:404-410.
3. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310.
4. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
5. Raj DS, Dominic EA, Osman F, et al. Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. Kidney Int. 2005;68(5):2338-2344.
6. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem. 2002;35(4):269-273.
7. Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol. 2003;35(3):393-397.
8. Donica H. Evaluation of lipids peroxidation products vs. proinflammatory cytokines in hemodialized patients. Ren Fail. 2001;23(2):231-238.